| 摘要 |
The invention described is a method and composition for inducing cell surface anti-thrombotic activity in endothelial cells comprising administering to a patient a therapeutically-effective amount of Rhamnan Sulphate. The dose of Rhamnan sulphate is equivalentto between approximately 8,000IU and 12,000IU of heparin activit y daily on variable schedule or optionally at single dosageof 7.5 mg/kg, that is repeated on a daily basis as needed, to lo wer the incidence of thrombus formation or to lower the incidenceof hard clot formation. |
